Original Research

Published on 25 Oct 2024

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia

in Pharmacology of Infectious Diseases

Xingchen Bian
Nanyang Li
Yi Li
Xu Zhu
Jicheng Yu
Yingying Hu
Haijing Yang
Qiong Wei
Xiaojie Wu
Jingjing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456741

327 views

Original Research

Published on 17 Oct 2024

Antifungal potential of marine bacterial compounds in inhibiting Candida albicans Yck2 to overcome echinocandin resistance: a molecular dynamics study

in Pharmacology of Infectious Diseases

Mohammed Merae Alshahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459964

403 views

Original Research

Published on 15 Oct 2024

Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2

in Pharmacology of Infectious Diseases

Md. Shohel Hossain
Soharth Hasnat
Shilpy Akter
Maria Mulla Mim
Anika Tahcin
Majedul Hoque
Durjoy Sutradhar
Mst. Alifa Akter Keya
Namin Rouf Sium
Sophia Hossain

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465827

1,676 views

Original Research

Published on 14 Oct 2024

Subinhibitory concentrations of antibiotics affect development and parameters of Helicobacter pylori biofilm

in Pharmacology of Infectious Diseases

Paweł Krzyżek
Paweł Migdał
Kaja Tusiewicz
Marcin Zawadzki
Paweł Szpot

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477317

719 views

Systematic Review

Published on 10 Oct 2024

Novel β-lactam antibiotics versus other antibiotics for treatment of complicated urinary tract infections: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Xiang hua Quan
Xin yi Wang
Chun hua Han
Xiao min Xing
Bin Zhang
Huai qin Cang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420170

510 views

Original Research

Published on 07 Oct 2024

Dimerization and lysine substitution of melittin have differing effects on bacteria

in Pharmacology of Infectious Diseases

Tamara Matthyssen
Wenyi Li
James A. Holden
Jason C. Lenzo
Sara Hadjigol
Neil M. O’Brien-Simpson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1443497

399 views

Review

Published on 30 Sep 2024

An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients

in Pharmacology of Infectious Diseases

Guanshuang Fu
Weijia Sun
Zhaoyi Tan
Beibei Liang
Yun Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396994

578 views

Original Research

Published on 23 Sep 2024

Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib

in Pharmacology of Infectious Diseases

Mario Manzanares
Fernando Ramos-Martín
Sara Rodríguez-Mora
Guiomar Casado-Fernández
Clara Sánchez-Menéndez
Alicia Simón-Rueda
Elena Mateos
Miguel Cervero
Adam M. Spivak
Vicente Planelles

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426974

755 views

Data Report

Published on 23 Sep 2024

ArboItaly: Leveraging open data for enhanced arbovirus surveillance in Italy

in Pharmacology of Infectious Diseases

Francesco Branda
Marta Giovanetti
Giancarlo Ceccarelli
Massimo Ciccozzi
Fabio Scarpa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459408

964 views

Review

Published on 17 Sep 2024

Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review

in Pharmacology of Infectious Diseases

Aref Shariati
Milad Kashi
Zahra Chegini
Seyed Mostafa Hosseini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467086

1,032 views

Editorial

Published on 17 Sep 2024

Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases

in Pharmacology of Infectious Diseases

Dariel Wilbert Tanoto
Jia Wen Lee
Yee Kien Chong
Rafidah Lani
Pouya Hassandarvish
Adrian Oo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486889

409 views

Original Research

Published on 13 Sep 2024

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis

in Pharmacology of Infectious Diseases

Joscha Borho
Merle Kögel
Amelie Eckert
Holger Barth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455696

717 views

Correction

Published on 03 Sep 2024

Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Mohammad Hosseini Hooshiar
Mohammad Sholeh
Masoumeh Beig
Khalil Azizian
Ebrahim Kouhsari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465628

598 views

Original Research

Published on 02 Sep 2024

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

in Pharmacology of Infectious Diseases

Ajay Manaithiya
Ratul Bhowmik
Kunal Bhattacharya
Rajarshi Ray
Sagar Singh Shyamal
Fabrizio Carta
Claudiu T. Supuran
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457012

1,248 views

Systematic Review

Published on 22 Aug 2024

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis

in Pharmacology of Infectious Diseases

Jian-Xin Peng
Ling-Zhi Wang
Qiu-Ting Wang
Hui-Long Li
Li-Jun Lin
Jun-Ming He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393861

1,068 views

Original Research

Published on 19 Aug 2024

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study

in Pharmacology of Infectious Diseases

Ye Qiu
Hao Wen
Haoru Wang
Wenjun Sun
Guangchao Li
Shaoqiang Li
Yan Wang
Jingnan Zhai
Yangqing Zhan
Yutian Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401658

1,770 views

Navigation group

Articles

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia

Antifungal potential of marine bacterial compounds in inhibiting Candida albicans Yck2 to overcome echinocandin resistance: a molecular dynamics study

Computational identification of Vernonia cinerea-derived phytochemicals as potential inhibitors of nonstructural protein 1 (NSP1) in dengue virus serotype-2

Subinhibitory concentrations of antibiotics affect development and parameters of Helicobacter pylori biofilm

Novel β-lactam antibiotics versus other antibiotics for treatment of complicated urinary tract infections: a systematic review and meta-analysis

Dimerization and lysine substitution of melittin have differing effects on bacteria

An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients

Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib

ArboItaly: Leveraging open data for enhanced arbovirus surveillance in Italy

Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review

Editorial: Raising the bar: advancing therapeutic strategies for fighting communicable and noncommunicable diseases

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis

Corrigendum: Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

A cheminformatics and network pharmacology approach to elucidate the mechanism of action of Mycobacterium tuberculosis γ-carbonic anhydrase inhibitors

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis

Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study